Wells Fargo’s Alder Biopharmaceuticals ALDR Stock Holding History

Wells Fargo’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-133,400	Closed	-$4K	–	6677
2018 Q4	$4K	Hold	133,400	–	–	﹤0.01%	6127
2018 Q3	$92K	Buy	133,400 +88,400	+196%	+$1.6M	﹤0.01%	5393
2018 Q2	$98K	Buy	+45,000	New	+$684K	﹤0.01%	5393

Wells Fargo's ALDR Position: Q4 2019 in Review

Wells Fargo sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 304,963 shares — an estimated $5.75M sold.

Wells Fargo first reported a position in ALDR in Q2 2014 and held it in 22 quarters. The position peaked at $14M in Q2 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Wells Fargo reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Wells Fargo sold 304,963 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5.75M.
Wells Fargo first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 22 quarters.
Wells Fargo's Alder Biopharmaceuticals position peaked at $14M in Q2 2016.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.